Since there are few clear tests of the disease???s progression, HGS devised a coding system to measure the drug???s effect on the severity of the participants??? symptoms.During an early phase of the trial, African Americans ??? who, for unknown reasons, are disproportionately affected by the disease ??? seemed to do particularly well on the drug, but in a larger, later trial, this group got almos